Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market

New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare’s immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials Telix tracers evaluate levels of carbonic anhydrase IX and lactate in tumours to inform and improve therapy selection GE Healthcare’s Pharmaceutical Diagnostics business is an established global supplier of PET imaging tracers... Read more

[Correction] Annual Securities Report for the Fiscal Year Ended March 31, 2022

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

[Delayed] Annual Securities Report for Fiscal Year Ended March 31, 2022

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations

Novel NMR Probe Technologies, GHz-class NMR and Dynamics Software Enable New Research, and Advance Functional Structural Biology and Drug Discovery BOSTON–(BUSINESS WIRE)– At the ICMRBS 2022 Conference, Bruker today announces a new 8 mm 15N TROSY Cryoprobe for enabling novel NMR functional structural biology investigations into larger globular proteins and protein complexes. The new technology... Read more